ARDX
ARDELYX, INC.
Company overview
- Market capitalization
- $849.73M
- Employees
- 489
- Latest publication
- 2026-09-29
About ARDELYX, INC.
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. Ardelyx, Inc. was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. The company was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
Financial statements
Income Quarterly
| Metric | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q3 20232023-09-30 · USD | Q4 20222022-12-31 · USD | Q2 20222022-06-30 · USD | Q1 20222022-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 125,215,000USD | 110,329,000USD | 116,129,000USD | 98,241,000USD | 56,391,000USD | 44,178,000USD | 2,526,000USD | 468,000USD |
| Cost Of Revenue | 11,770,000USD | 4,887,000USD | 18,264,000USD | 15,728,000USD | 7,692,000USD | 3,162,000USD | 138,000USD | 85,000USD |
| Gross Profit | 113,445,000USD | 105,442,000USD | 97,865,000USD | 82,513,000USD | 48,699,000USD | 41,016,000USD | 2,388,000USD | 383,000USD |
| Research Development | 21,935,000USD | 17,162,000USD | 13,666,000USD | 15,310,000USD | 8,637,000USD | 9,142,000USD | 9,741,000USD | 8,851,000USD |
| Selling General Administrative | 86,411,000USD | 83,612,000USD | 76,074,000USD | 64,970,000USD | 32,664,000USD | 19,731,000USD | 18,862,000USD | 19,339,000USD |
| Total Operating Expenses | 108,346,000USD | 100,774,000USD | 89,740,000USD | 80,280,000USD | 41,301,000USD | 28,873,000USD | 28,603,000USD | 28,190,000USD |
| Operating Income | 5,099,000USD | 4,668,000USD | 8,125,000USD | 2,233,000USD | 7,398,000USD | 12,143,000USD | -26,215,000USD | -27,807,000USD |
| Interest Expense | 7,577,000USD | 7,984,000USD | 5,853,000USD | 5,281,000USD | 2,029,000USD | 1,823,000USD | 787,000USD | 746,000USD |
| Net Interest Income | -7,577,000USD | -7,984,000USD | -5,853,000USD | -5,281,000USD | -2,029,000USD | -1,823,000USD | -787,000USD | -746,000USD |
| Income Before Tax | -400,000USD | -867,000USD | 4,680,000USD | -766,000USD | 6,829,000USD | 10,695,000USD | -26,932,000USD | -28,069,000USD |
| Income Tax Expense | 7,000USD | 102,000USD | 35,000USD | 43,000USD | 200,000USD | -109,000USD | 6,000USD | 2,000USD |
| Tax Provision | 7,000USD | 102,000USD | 35,000USD | 43,000USD | 200,000USD | 0USD | 6,000USD | 2,000USD |
| Net Income | -407,000USD | -969,000USD | 4,645,000USD | -809,000USD | 6,629,000USD | 10,695,000USD | -26,938,000USD | -28,071,000USD |
| Net Income From Continuing Ops | -407,000USD | -969,000USD | 4,645,000USD | -809,000USD | 6,629,000USD | 10,695,000USD | -26,938,000USD | -28,071,000USD |
| Ebit | 7,177,000USD | 7,117,000USD | 10,533,000USD | 4,515,000USD | 8,858,000USD | 12,518,000USD | -26,115,000USD | -27,323,000USD |
| Ebitda | 8,098,000USD | 8,022,000USD | 11,048,000USD | 5,059,000USD | 9,149,000USD | 13,514,000USD | -25,870,000USD | -26,860,000USD |
| Depreciation And Amortization | 921,000USD | 905,000USD | 515,000USD | 544,000USD | 291,000USD | 996,000USD | 245,000USD | 463,000USD |
| Reconciled Depreciation | 921,000USD | 905,000USD | 515,000USD | 544,000USD | 291,000USD | 109,000USD | 175,000USD | 232,000USD |
| Total Other Income Expense Net | -5,499,000USD | -5,535,000USD | -3,445,000USD | -2,999,000USD | -569,000USD | -1,448,000USD | -717,000USD | -262,000USD |
| Non Operating Income Net Other | — | — | — | — | — | 375,000USD | 70,000USD | 484,000USD |
| Net Income Applicable To Common Shares | — | — | — | — | — | 10,695,000USD | -26,938,000USD | -28,071,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD | FY 20162016-12-31 · USD | FY 20152015-12-31 · USD | FY 20142014-12-31 · USD | FY 20132013-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 10,097,000USD | 7,571,000USD | 5,281,000USD | 2,607,000USD | 24,026,000USD | 24,026,000USD | 31,623,000USD | 28,928,000USD |
| Cost Of Revenue | 1,000,000USD | 145,000USD | 600,000USD | 466,000USD | 1,295,000USD | 1,327,000USD | 32,885,000USD | 28,093,000USD |
| Gross Profit | 9,097,000USD | 7,426,000USD | 4,681,000USD | 2,141,000USD | 22,731,000USD | 24,026,000USD | 31,623,000USD | 835,000USD |
| Research Development | 91,140,000USD | 65,053,000USD | 71,677,000USD | 69,373,000USD | 94,161,000USD | 39,885,000USD | 25,900,000USD | 28,093,000USD |
| Selling General Administrative | 72,303,000USD | 33,153,000USD | 24,267,000USD | 23,715,000USD | 18,734,000USD | 13,530,000USD | 7,287,000USD | 3,700,000USD |
| Total Operating Expenses | 163,443,000USD | 98,206,000USD | 95,944,000USD | 93,088,000USD | 112,895,000USD | 53,415,000USD | 33,187,000USD | 31,793,000USD |
| Operating Income | -154,346,000USD | -90,780,000USD | -91,263,000USD | -90,947,000USD | -112,895,000USD | -29,389,000USD | -1,564,000USD | -2,865,000USD |
| Interest Expense | 4,502,000USD | 5,099,000USD | 5,726,000USD | 3,534,000USD | 0USD | 0USD | 0USD | 0USD |
| Net Interest Income | -4,502,000USD | -5,099,000USD | -5,726,000USD | -3,534,000USD | — | — | — | — |
| Income Before Tax | -158,161,000USD | -94,311,000USD | -94,637,000USD | -91,294,000USD | -112,387,000USD | -29,650,000USD | -3,147,000USD | -6,423,000USD |
| Income Tax Expense | 4,000USD | 2,000USD | 303,000USD | 4,000USD | 29,000USD | -29,000USD | 67,000USD | 141,000USD |
| Tax Provision | 4,000USD | 2,000USD | 303,000USD | 4,000USD | 0USD | -29,000USD | — | — |
| Net Income | -158,165,000USD | -94,313,000USD | -94,940,000USD | -91,298,000USD | -112,387,000USD | -29,621,000USD | -3,214,000USD | -6,564,000USD |
| Net Income From Continuing Ops | -158,165,000USD | -94,313,000USD | -94,940,000USD | -91,298,000USD | -112,387,000USD | -29,621,000USD | -3,214,000USD | — |
| Ebit | -153,659,000USD | -89,212,000USD | -88,911,000USD | -87,760,000USD | -112,895,000USD | -29,389,000USD | -1,564,000USD | -2,865,000USD |
| Ebitda | -150,852,000USD | -85,241,000USD | -84,571,000USD | -85,082,000USD | -111,600,000USD | -28,560,000USD | -1,262,000USD | -2,273,000USD |
| Depreciation And Amortization | 2,807,000USD | 3,971,000USD | 4,340,000USD | 2,678,000USD | 1,295,000USD | 829,000USD | 302,000USD | 592,000USD |
| Reconciled Depreciation | 1,441,000USD | 1,824,000USD | 2,501,000USD | 2,678,000USD | — | — | — | — |
| Total Other Income Expense Net | -3,815,000USD | -3,531,000USD | -3,374,000USD | -347,000USD | 508,000USD | -261,000USD | -1,583,000USD | -3,558,000USD |
| Non Operating Income Net Other | 687,000USD | 1,568,000USD | 2,352,000USD | 3,187,000USD | 508,000USD | -261,000USD | -1,583,000USD | — |
| Net Income Applicable To Common Shares | -158,165,000USD | -94,313,000USD | -94,940,000USD | -91,298,000USD | -112,387,000USD | -29,621,000USD | -3,214,000USD | — |
| Interest Income | — | — | 5,786,560USD | 127,728,000USD | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 504,507,000USD | 502,808,000USD | 486,170,000USD | 466,770,000USD | 410,194,000USD | 435,754,000USD | 367,863,000USD | 343,488,000USD |
| Other Current Assets | 38,211,000USD | 28,045,000USD | 23,498,000USD | 28,289,000USD | 28,497,000USD | 27,474,000USD | 29,123,000USD | 26,062,000USD |
| Total Liab | 355,885,000USD | 335,859,000USD | 331,890,000USD | 327,239,000USD | 264,518,000USD | 262,465,000USD | 209,566,000USD | 196,498,000USD |
| Total Stockholder Equity | 148,622,000USD | 166,949,000USD | 154,280,000USD | 139,531,000USD | 145,676,000USD | 173,289,000USD | 158,297,000USD | 146,990,000USD |
| Other Current Liab | 76,615,000USD | 66,685,000USD | 56,983,000USD | 52,575,000USD | 49,903,000USD | 49,582,000USD | 44,836,000USD | 37,176,000USD |
| Common Stock | 25,000USD | 24,000USD | 24,000USD | 24,000USD | 24,000USD | 24,000USD | 24,000USD | 23,000USD |
| Capital Stock | 25,000USD | 24,000USD | 24,000USD | 24,000USD | 24,000USD | 24,000USD | 24,000USD | 23,000USD |
| Retained Earnings | -984,544,000USD | -946,939,000USD | -946,532,000USD | -945,563,000USD | -926,484,000USD | -885,340,000USD | -889,985,000USD | -889,176,000USD |
| Cash | 31,209,000USD | 67,999,000USD | 42,715,000USD | 90,045,000USD | 30,808,000USD | 64,932,000USD | 47,429,000USD | 41,890,000USD |
| Cash And Short Term Investments | 238,074,000USD | 264,689,000USD | 242,705,000USD | 238,452,000USD | 213,952,000USD | 250,100,000USD | 190,402,000USD | 185,961,000USD |
| Total Current Assets | 381,870,000USD | 382,317,000USD | 367,985,000USD | 351,569,000USD | 312,692,000USD | 356,452,000USD | 284,098,000USD | 263,020,000USD |
| Total Current Liabilities | 109,568,000USD | 88,605,000USD | 83,389,000USD | 81,722,000USD | 75,840,000USD | 77,830,000USD | 70,499,000USD | 62,436,000USD |
| Current Deferred Revenue | 3,248,000USD | 1,206,000USD | 6,581,000USD | 6,280,000USD | 10,913,000USD | 10,686,000USD | 7,272,000USD | 10,829,000USD |
| Net Debt | 177,055,000USD | 143,596,000USD | 164,896,000USD | 116,598,000USD | 124,300,000USD | 88,506,000USD | 57,063,000USD | 63,005,000USD |
| Short Term Debt | 1,510,000USD | 1,479,000USD | 1,435,000USD | 1,182,000USD | 1,302,000USD | 1,562,000USD | 2,567,000USD | 3,550,000USD |
| Short Long Term Debt Total | 208,264,000USD | 211,595,000USD | 207,611,000USD | 206,643,000USD | 155,108,000USD | 153,438,000USD | 104,492,000USD | 104,895,000USD |
| Long Term Debt | 203,517,000USD | 202,834,000USD | 202,138,000USD | 201,446,000USD | 151,301,000USD | 150,853,000USD | 100,707,000USD | 100,249,000USD |
| Short Term Investments | 206,865,000USD | 196,690,000USD | 199,990,000USD | 148,407,000USD | 183,144,000USD | 185,168,000USD | 142,973,000USD | 144,071,000USD |
| Net Receivables | 82,840,000USD | 71,848,000USD | 76,610,000USD | 62,553,000USD | 46,467,000USD | 57,705,000USD | 53,195,000USD | 37,241,000USD |
| Inventory | 22,745,000USD | 17,735,000USD | 25,172,000USD | 22,275,000USD | 23,776,000USD | 21,173,000USD | 11,378,000USD | 13,756,000USD |
| Accounts Payable | 28,195,000USD | 19,235,000USD | 18,390,000USD | 21,685,000USD | 13,722,000USD | 16,000,000USD | 15,824,000USD | 10,881,000USD |
| Property Plant Equipment Net | 6,435,000USD | 6,979,000USD | 7,221,000USD | 7,149,000USD | 5,335,000USD | 3,875,000USD | 4,653,000USD | 5,340,000USD |
| Property Plant Equipment Gross | 6,435,000USD | 9,629,000USD | 7,221,000USD | 7,149,000USD | 5,335,000USD | 14,493,000USD | 4,653,000USD | 5,340,000USD |
| Accumulated Other Comprehensive Income | -124,000USD | 198,000USD | 124,000USD | -38,000USD | 18,000USD | 57,000USD | 185,000USD | -101,000USD |
| Common Stock Shares Outstanding | 245,855,082shares | 243,614,026shares | 241,908,407shares | 239,928,570shares | 238,624,145shares | 244,050,606shares | 235,911,399shares | 234,571,192shares |
| Non Current Assets Total | 122,637,000USD | 120,490,999USD | 118,185,000USD | 115,201,000USD | 97,502,000USD | 79,302,000USD | 83,765,000USD | 80,468,000USD |
| Non Current Liabilities Total | 246,317,000USD | 247,253,999USD | 248,501,000USD | 245,517,000USD | 188,678,000USD | 184,635,000USD | 139,067,000USD | 134,062,000USD |
| Non Currrent Assets Other | 116,202,000USD | 112,307,999USD | 110,964,000USD | 108,052,000USD | 92,167,000USD | 75,427,000USD | 79,112,000USD | 75,128,000USD |
| Net Working Capital | 272,302,000USD | 293,712,000USD | 284,596,000USD | 269,847,000USD | 236,852,000USD | 278,622,000USD | 213,599,000USD | 200,584,000USD |
| Unclassified Non Current Liabilities | 42,800,000USD | 44,419,999USD | 46,363,000USD | 44,071,000USD | 37,377,000USD | 33,782,000USD | 38,360,000USD | 33,813,000USD |
| Unclassified Equity | 1,133,240,000USD | 1,113,642,000USD | 1,100,640,000USD | 1,085,084,000USD | 1,072,094,000USD | 1,058,524,000USD | 1,048,049,000USD | 1,036,221,000USD |
| Other Assets | — | — | — | — | — | — | — | 1USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 501,604,000USD | 435,754,000USD | 297,579,000USD | 190,066,000USD | 149,913,000USD | 201,562,000USD | 259,782,000USD | 183,332,000USD |
| Other Current Assets | 28,045,000USD | 27,474,000USD | 27,333,000USD | 18,679,000USD | 16,458,000USD | 8,202,000USD | 3,800,000USD | 4,547,000USD |
| Total Liab | 334,655,000USD | 262,465,000USD | 130,763,000USD | 91,737,000USD | 67,296,000USD | 75,450,000USD | 73,127,000USD | 67,519,000USD |
| Total Stockholder Equity | 166,949,000USD | 173,289,000USD | 166,816,000USD | 98,329,000USD | 82,617,000USD | 126,112,000USD | 186,655,000USD | 115,813,000USD |
| Other Current Liab | 66,685,000USD | 49,582,000USD | 27,638,000USD | 19,928,000USD | 12,788,000USD | 10,212,000USD | 9,093,000USD | 585,000USD |
| Common Stock | 24,000USD | 24,000USD | 23,000USD | 20,000USD | 13,000USD | 9,000USD | 9,000USD | 6,000USD |
| Capital Stock | 24,000USD | 24,000USD | 23,000USD | 20,000USD | 13,000USD | 9,000USD | 9,000USD | 6,000USD |
| Retained Earnings | -946,939,000USD | -885,340,000USD | -846,204,000USD | -780,137,000USD | -712,930,000USD | -554,765,000USD | -460,452,000USD | -365,512,000USD |
| Cash | 67,999,000USD | 64,932,000USD | 21,470,000USD | 96,140,000USD | 72,428,000USD | 91,032,000USD | 181,133,000USD | 78,768,000USD |
| Cash And Short Term Investments | 264,689,000USD | 250,100,000USD | 184,299,000USD | 123,909,000USD | 116,689,000USD | 186,484,000USD | 247,512,000USD | 168,089,000USD |
| Total Current Assets | 382,317,000USD | 356,452,000USD | 246,111,000USD | 153,603,000USD | 133,649,000USD | 195,238,000USD | 252,376,000USD | 177,721,000USD |
| Total Current Liabilities | 88,605,000USD | 77,830,000USD | 50,393,000USD | 65,603,000USD | 52,821,000USD | 28,416,000USD | 22,220,000USD | 17,728,000USD |
| Current Deferred Revenue | 1,206,000USD | 10,686,000USD | 7,182,000USD | 4,211,000USD | 4,727,000USD | 4,177,000USD | 4,541,000USD | 1,000,000USD |
| Net Debt | 143,596,000USD | 88,506,000USD | 34,512,000USD | -59,680,000USD | -26,924,000USD | -35,597,000USD | -123,827,000USD | -29,559,000USD |
| Short Term Debt | 1,479,000USD | 1,562,000USD | 4,435,000USD | 30,605,000USD | 35,756,000USD | 8,401,000USD | 6,399,000USD | 585,000USD |
| Short Long Term Debt Total | 211,595,000USD | 153,438,000USD | 55,982,000USD | 36,460,000USD | 45,504,000USD | 55,435,000USD | 57,306,000USD | 49,794,000USD |
| Long Term Debt | 202,834,000USD | 150,853,000USD | 49,822,000USD | — | — | 46,621,000USD | 48,831,000USD | 49,209,000USD |
| Short Term Investments | 196,690,000USD | 185,168,000USD | 162,829,000USD | 27,769,000USD | 44,261,000USD | 95,452,000USD | 66,379,000USD | 89,321,000USD |
| Net Receivables | 71,848,000USD | 57,705,000USD | 22,031,000USD | 7,733,000USD | 502,000USD | 0USD | 750,000USD | 5,085,000USD |
| Inventory | 17,735,000USD | 21,173,000USD | 12,448,000USD | 3,282,000USD | 1,150,000USD | — | 1USD | — |
| Accounts Payable | 19,235,000USD | 16,000,000USD | 11,138,000USD | 10,859,000USD | 4,277,000USD | 5,626,000USD | 2,187,000USD | 16,728,000USD |
| Property Plant Equipment Net | 6,979,000USD | 3,875,000USD | 6,598,000USD | 10,518,000USD | 15,114,000USD | 4,210,000USD | 7,406,000USD | 5,611,000USD |
| Property Plant Equipment Gross | 9,629,000USD | 14,493,000USD | 16,799,000USD | 1,223,000USD | 15,114,000USD | 4,210,000USD | 7,406,000USD | 5,611,000USD |
| Accumulated Other Comprehensive Income | 198,000USD | 57,000USD | 224,000USD | -54,000USD | -6,000USD | -4,000USD | 20,000USD | -38,000USD |
| Common Stock Shares Outstanding | 241,033,750shares | 235,233,000shares | 219,331,253shares | 158,690,083shares | 104,205,645shares | 89,582,138shares | 64,478,066shares | 56,219,919shares |
| Non Current Assets Total | 119,287,000USD | 79,302,000USD | 51,468,000USD | 36,463,000USD | 16,264,000USD | 6,324,000USD | 7,406,000USD | 5,611,000USD |
| Non Current Liabilities Total | 246,050,000USD | 184,635,000USD | 80,370,000USD | 26,134,000USD | 14,475,000USD | 47,034,000USD | 50,907,000USD | 49,791,000USD |
| Non Currrent Assets Other | 112,308,000USD | 75,427,000USD | 44,870,000USD | 25,945,000USD | 1,150,000USD | 552,000USD | 314,000USD | 1,350,000USD |
| Net Working Capital | 293,712,000USD | 278,622,000USD | 195,718,000USD | 88,000,000USD | 80,828,000USD | 166,270,000USD | 229,842,000USD | 158,643,000USD |
| Unclassified Non Current Liabilities | 43,216,000USD | 33,782,000USD | 30,548,000USD | -11,254,000USD | -4,727,000USD | — | — | — |
| Unclassified Equity | 1,113,642,000USD | 1,058,524,000USD | 1,012,750,000USD | 878,480,000USD | 795,527,000USD | 680,863,000USD | 647,069,000USD | 481,351,000USD |
| Other Liab | — | — | — | 20,279,000USD | 4,727,000USD | — | — | 582,000USD |
| Other Assets | — | — | — | 25,945,000USD | 1,150,000USD | 552,000USD | 314,000USD | 1,350,000USD |
| Short Long Term Debt | — | — | — | 26,711,000USD | 32,264,000USD | 4,167,000USD | 1,183,000USD | — |
| Non Current Liabilities Other | — | — | — | 17,109,000USD | 14,475,000USD | 413,000USD | 2,076,000USD | 582,000USD |
| Net Tangible Assets | — | — | — | 98,329,000USD | 82,617,000USD | 126,112,000USD | 186,655,000USD | 115,813,000USD |
| Unclassified Non Current Assets | — | — | — | -25,945,000USD | -1,150,000USD | -1,104,000USD | — | -2,700,000USD |
| Unclassified Current Liabilities | — | — | — | -26,711,000USD | -36,991,000USD | -4,167,000USD | -1,183,000USD | -1,170,000USD |
| Long Term Investments | — | — | — | — | 0USD | 2,114,000USD | 0USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -37,605,000USD | -407,000USD | -969,000USD | -19,079,000USD | -41,144,000USD | 4,645,000USD | -809,000USD | -16,454,000USD |
| Depreciation | 915,000USD | 921,000USD | 905,000USD | 631,000USD | 602,000USD | 515,000USD | 544,000USD | 569,000USD |
| Stock Based Compensation | 14,158,000USD | 12,445,000USD | 12,742,000USD | 11,687,000USD | 12,088,000USD | 9,863,000USD | 9,133,000USD | 10,769,000USD |
| Other Non Cash Items | -1,985,000USD | 326,000USD | -3,069,000USD | 348,000USD | 842,000USD | 1,012,000USD | 1,126,000USD | 478,000USD |
| Change To Account Receivables | -10,992,000USD | 4,762,000USD | -14,057,000USD | -16,086,000USD | 11,238,000USD | -4,510,000USD | -15,954,000USD | -9,079,000USD |
| Change To Inventory | -4,918,000USD | 6,251,000USD | -6,099,000USD | -17,383,000USD | -14,692,000USD | -6,026,000USD | -1,726,000USD | -4,574,000USD |
| Change In Working Capital | -7,720,000USD | 7,666,000USD | -9,244,000USD | -18,929,000USD | -10,845,000USD | -6,225,000USD | -9,493,000USD | -14,760,000USD |
| Total Cash From Operating Activities | -32,237,000USD | 20,951,000USD | 365,000USD | -25,342,000USD | -38,457,000USD | 9,810,000USD | 501,000USD | -19,398,000USD |
| Capital Expenditures | -69,000USD | -361,000USD | -156,000USD | -650,000USD | -325,000USD | -593,000USD | -137,000USD | -131,000USD |
| Free Cash Flow | -32,306,000USD | 20,590,000USD | 209,000USD | -25,992,000USD | -38,782,000USD | 9,217,000USD | 364,000USD | -19,529,000USD |
| Investments | -9,926,000USD | 4,137,000USD | -50,509,000USD | 34,923,000USD | 2,851,000USD | -41,620,000USD | 2,341,000USD | 23,533,000USD |
| Total Cashflows From Investing Activities | -9,995,000USD | 3,776,000USD | -50,509,000USD | 34,923,000USD | 2,851,000USD | -41,620,000USD | 2,341,000USD | 23,533,000USD |
| Total Cash From Financing Activities | 5,442,000USD | 557,000USD | 2,814,000USD | 49,656,000USD | 1,482,000USD | 49,313,000USD | 2,697,000USD | 1,608,000USD |
| Change In Cash | -36,790,000USD | 25,284,000USD | -47,330,000USD | 59,237,000USD | -34,124,000USD | 17,503,000USD | 5,539,000USD | 5,743,000USD |
| Begin Period Cash Flow | 67,999,000USD | 42,715,000USD | 90,045,000USD | 30,808,000USD | 64,932,000USD | 47,429,000USD | 41,890,000USD | 36,147,000USD |
| End Period Cash Flow | 31,209,000USD | 67,999,000USD | 42,715,000USD | 90,045,000USD | 30,808,000USD | 64,932,000USD | 47,429,000USD | 41,890,000USD |
| Net Borrowings | — | 0USD | 0USD | 48,668,000USD | 0USD | 49,701,000USD | 0USD | — |
| Sale Purchase Of Stock | — | — | 2,814,000USD | 988,000USD | 1,482,000USD | — | 4,305,000USD | — |
| Other Cashflows From Financing Activities | — | — | 2,814,000USD | 48,353,000USD | 1,482,000USD | -388,000USD | 2,341,000USD | 1,608,000USD |
| Unclassified Financing Cash Flow | — | — | -2,814,000USD | -48,353,000USD | -1,482,000USD | — | -3,949,000USD | — |
| Issuance Of Capital Stock | — | — | — | — | — | 0USD | 0USD | 0USD |
| Other Cashflows From Investing Activities | — | — | — | — | — | — | — | 23,664,000USD |
| Unclassified Investing Cash Flow | — | — | — | — | — | — | — | -23,533,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -61,599,000USD | -39,136,000USD | -66,067,000USD | -67,207,000USD | -158,165,000USD | -94,313,000USD | -94,940,000USD | -91,298,000USD |
| Depreciation | 3,059,000USD | 2,063,000USD | 1,292,000USD | 1,144,000USD | 1,441,000USD | 1,824,000USD | 2,501,000USD | 2,678,000USD |
| Stock Based Compensation | 48,962,000USD | 37,381,000USD | 13,530,000USD | 10,750,000USD | 12,039,000USD | 10,583,000USD | 9,936,000USD | 9,226,000USD |
| Other Non Cash Items | -1,553,000USD | 4,052,000USD | 4,914,000USD | 4,844,000USD | 4,246,000USD | 3,369,000USD | 3,296,000USD | 792,000USD |
| Change To Account Receivables | -14,143,000USD | -35,674,000USD | -14,298,000USD | -7,231,000USD | -502,000USD | 750,000USD | 85,000USD | 10,711,000USD |
| Change To Inventory | -31,923,000USD | -41,697,000USD | -21,141,000USD | -28,346,000USD | -10,371,000USD | -750,000USD | -3,410,000USD | 1,878,000USD |
| Change In Working Capital | -31,352,000USD | -49,169,000USD | -43,386,000USD | -19,575,000USD | -11,922,000USD | -3,213,000USD | 2,985,000USD | 9,353,000USD |
| Total Cash From Operating Activities | -42,483,000USD | -44,809,000USD | -89,717,000USD | -70,044,000USD | -152,551,000USD | -81,435,000USD | -76,484,000USD | -70,274,000USD |
| Capital Expenditures | -1,492,000USD | -1,011,000USD | -344,000USD | -55,000USD | -1,867,000USD | -324,000USD | -325,000USD | -311,000USD |
| Free Cash Flow | -43,975,000USD | -45,820,000USD | -90,061,000USD | -70,099,000USD | -154,418,000USD | -81,759,000USD | -76,809,000USD | -70,585,000USD |
| Investments | -7,467,000USD | -18,318,000USD | -100,240,000USD | 16,672,000USD | 52,815,000USD | -31,118,000USD | 23,698,000USD | -29,583,000USD |
| Total Cashflows From Investing Activities | -8,959,000USD | -18,318,000USD | -131,248,000USD | 18,415,000USD | 50,948,000USD | -31,442,000USD | 23,373,000USD | -29,894,000USD |
| Net Borrowings | 48,668,000USD | 99,451,000USD | 22,386,000USD | -6,067,000USD | -19,444,000USD | -125,000USD | -125,000USD | 49,292,000USD |
| Total Cash From Financing Activities | 54,509,000USD | 106,589,000USD | 146,295,000USD | 75,341,000USD | 82,999,000USD | 22,776,000USD | 155,476,000USD | 103,553,000USD |
| Issuance Of Capital Stock | 0USD | 0USD | 138,028,000USD | 71,625,000USD | 101,146,000USD | 21,047,000USD | 154,902,000USD | 53,770,000USD |
| Change In Cash | 3,067,000USD | 43,462,000USD | -74,670,000USD | 23,712,000USD | -18,604,000USD | -90,101,000USD | 102,365,000USD | 3,385,000USD |
| Begin Period Cash Flow | 64,932,000USD | 21,470,000USD | 96,140,000USD | 72,428,000USD | 91,032,000USD | 181,133,000USD | 78,768,000USD | 75,383,000USD |
| End Period Cash Flow | 67,999,000USD | 64,932,000USD | 21,470,000USD | 96,140,000USD | 72,428,000USD | 91,032,000USD | 181,133,000USD | 78,768,000USD |
| Other Cashflows From Financing Activities | 54,509,000USD | -1,000,000USD | 4,673,000USD | 9,783,000USD | 1,297,000USD | 1,854,000USD | 574,000USD | 491,000USD |
| Unclassified Financing Cash Flow | -48,668,000USD | — | 143,949,000USD | — | 101,358,000USD | -1,854,000USD | — | — |
| Sale Purchase Of Stock | — | 8,138,000USD | 1,173,000USD | 71,827,000USD | -106,000USD | 22,901,000USD | 155,105,000USD | 54,261,000USD |
| Unclassified Investing Cash Flow | — | 1,011,000USD | -30,664,000USD | — | -52,815,000USD | 31,442,000USD | -23,698,000USD | 29,583,000USD |
| Dividends Paid | — | — | -25,886,000USD | — | -106,000USD | — | — | — |
| Change To Liabilities | — | — | — | 21,355,000USD | -799,000USD | 3,294,000USD | 449,000USD | -1,883,000USD |
| Cash And Cash Equivalents Changes | — | — | — | 23,712,000USD | -18,604,000USD | -90,101,000USD | 102,365,000USD | 3,385,000USD |
| Other Cashflows From Investing Activities | — | — | — | 1,798,000USD | 52,815,000USD | -31,442,000USD | 23,698,000USD | -29,583,000USD |
| Unclassified Operating Cash Flow | — | — | — | — | — | — | — | -1,025,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Product | License | 51,000 | USD | 0001437402-26-000022 |
| Q1 2026Quarterly · 2026-03-31 | Product | Non Cash Royalty Related To Sale Of Future Royalties | 695,000 | USD | 0001437402-26-000022 |
| Q1 2026Quarterly · 2026-03-31 | Product | Product IBSRELA | 70,074,000 | USD | 0001437402-26-000022 |
| Q1 2026Quarterly · 2026-03-31 | Product | Product Supply Revenue | 354,000 | USD | 0001437402-26-000022 |
| Q1 2026Quarterly · 2026-03-31 | Product | Product XPHOZAH | 23,299,000 | USD | 0001437402-26-000022 |
| Q4 2025Quarterly · 2025-12-31 | Product | License | 23,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Non Cash Royalty Related To Sale Of Future Royalties | 1,350,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Product IBSRELA | 86,601,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Product Supply Revenue | 9,440,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Product XPHOZAH | 27,801,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Geography | Asia Pacific | 29,170,000 | USD | 0001437402-26-000013 |
| FY 2025Yearly · 2025-12-31 | Geography | North America | 342,000 | USD | 0001437402-26-000013 |
| FY 2025Yearly · 2025-12-31 | Geography | United States | 377,808,000 | USD | 0001437402-26-000013 |
| FY 2025Yearly · 2025-12-31 | Product | License | 5,088,000 | USD | 0001437402-26-000013 |
| FY 2025Yearly · 2025-12-31 | Product | Non Cash Royalty Related To Sale Of Future Royalties | 8,545,000 | USD | 0001437402-26-000013 |
| FY 2025Yearly · 2025-12-31 | Product | Product IBSRELA | 274,207,000 | USD | 0001437402-26-000013 |
| FY 2025Yearly · 2025-12-31 | Product | Product Supply Revenue | 15,879,000 | USD | 0001437402-26-000013 |
| FY 2025Yearly · 2025-12-31 | Product | Product XPHOZAH | 103,601,000 | USD | 0001437402-26-000013 |
| Q3 2025Quarterly · 2025-09-30 | Product | License | 25,000 | USD | 0001437402-25-000018 |
| Q3 2025Quarterly · 2025-09-30 | Product | Non Cash Royalty Related To Sale Of Future Royalties | 4,789,000 | USD | 0001437402-25-000018 |
| Q3 2025Quarterly · 2025-09-30 | Product | Product IBSRELA | 78,158,000 | USD | 0001437402-25-000018 |
| Q3 2025Quarterly · 2025-09-30 | Product | Product Supply Revenue | 0 | USD | 0001437402-25-000018 |
| Q3 2025Quarterly · 2025-09-30 | Product | Product XPHOZAH | 27,357,000 | USD | 0001437402-25-000018 |
| Q2 2025Quarterly · 2025-06-30 | Product | License | 20,000 | USD | 0001628280-25-037464 |
| Q2 2025Quarterly · 2025-06-30 | Product | Non Cash Royalty Related To Sale Of Future Royalties | 1,380,000 | USD | 0001628280-25-037464 |
| Q2 2025Quarterly · 2025-06-30 | Product | Product IBSRELA | 65,045,000 | USD | 0001628280-25-037464 |
| Q2 2025Quarterly · 2025-06-30 | Product | Product Supply Revenue | 6,185,000 | USD | 0001628280-25-037464 |
| Q2 2025Quarterly · 2025-06-30 | Product | Product XPHOZAH | 25,032,000 | USD | 0001628280-25-037464 |
| Q1 2025Quarterly · 2025-03-31 | Product | License | 5,020,000 | USD | 0001437402-26-000022 |
| Q1 2025Quarterly · 2025-03-31 | Product | Non Cash Royalty Related To Sale Of Future Royalties | 1,026,000 | USD | 0001437402-26-000022 |
| Q1 2025Quarterly · 2025-03-31 | Product | Product IBSRELA | 44,403,000 | USD | 0001437402-26-000022 |
| Q1 2025Quarterly · 2025-03-31 | Product | Product Supply Revenue | 254,000 | USD | 0001437402-26-000022 |
| Q1 2025Quarterly · 2025-03-31 | Product | Product XPHOZAH | 23,411,000 | USD | 0001437402-26-000022 |
| Q4 2024Quarterly · 2024-12-31 | Product | License | 22,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Non Cash Royalty Related To Sale Of Future Royalties | 916,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Product IBSRELA | 53,842,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Product Supply Revenue | 4,188,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Product XPHOZAH | 57,161,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Geography | Asia Pacific | 14,341,000 | USD | 0001437402-26-000013 |
| FY 2024Yearly · 2024-12-31 | Geography | North America | 78,000 | USD | 0001437402-26-000013 |
| FY 2024Yearly · 2024-12-31 | Geography | United States | 319,196,000 | USD | 0001437402-26-000013 |
| FY 2024Yearly · 2024-12-31 | Product | License | 78,000 | USD | 0001437402-26-000013 |
| FY 2024Yearly · 2024-12-31 | Product | Non Cash Royalty Related To Sale Of Future Royalties | 2,692,000 | USD | 0001437402-26-000013 |
| FY 2024Yearly · 2024-12-31 | Product | Product IBSRELA | 158,286,000 | USD | 0001437402-26-000013 |
| FY 2024Yearly · 2024-12-31 | Product | Product Supply Revenue | 11,649,000 | USD | 0001437402-26-000013 |
| FY 2024Yearly · 2024-12-31 | Product | Product XPHOZAH | 160,910,000 | USD | 0001437402-26-000013 |
| Q3 2024Quarterly · 2024-09-30 | Product | License | 20,000 | USD | 0001437402-25-000018 |
| Q3 2024Quarterly · 2024-09-30 | Product | Non Cash Royalty Related To Sale Of Future Royalties | 809,000 | USD | 0001437402-25-000018 |
| Q3 2024Quarterly · 2024-09-30 | Product | Product IBSRELA | 40,638,000 | USD | 0001437402-25-000018 |
| Q3 2024Quarterly · 2024-09-30 | Product | Product Supply Revenue | 5,322,000 | USD | 0001437402-25-000018 |
| Q3 2024Quarterly · 2024-09-30 | Product | Product XPHOZAH | 51,452,000 | USD | 0001437402-25-000018 |
| Q2 2024Quarterly · 2024-06-30 | Product | License | 19,000 | USD | 0001628280-25-037464 |
| Q2 2024Quarterly · 2024-06-30 | Product | Non Cash Royalty Related To Sale Of Future Royalties | 599,000 | USD | 0001628280-25-037464 |
| Q2 2024Quarterly · 2024-06-30 | Product | Product IBSRELA | 35,445,000 | USD | 0001628280-25-037464 |
| Q2 2024Quarterly · 2024-06-30 | Product | Product Supply Revenue | 13,000 | USD | 0001628280-25-037464 |
| Q2 2024Quarterly · 2024-06-30 | Product | Product XPHOZAH | 37,146,000 | USD | 0001628280-25-037464 |
| FY 2023Yearly · 2023-12-31 | Geography | Asia Pacific | 41,121,000 | USD | 0001437402-26-000013 |
| FY 2023Yearly · 2023-12-31 | Geography | North America | 59,000 | USD | 0001437402-26-000013 |
| FY 2023Yearly · 2023-12-31 | Geography | United States | 83,276,000 | USD | 0001437402-26-000013 |
| FY 2023Yearly · 2023-12-31 | Product | License | 35,809,000 | USD | 0001437402-26-000013 |
| FY 2023Yearly · 2023-12-31 | Product | Non Cash Royalty Related To Sale Of Future Royalties | 0 | USD | 0001437402-26-000013 |
| FY 2023Yearly · 2023-12-31 | Product | Product IBSRELA | 80,062,000 | USD | 0001437402-26-000013 |
| FY 2023Yearly · 2023-12-31 | Product | Product Supply Revenue | 6,121,000 | USD | 0001437402-26-000013 |
| FY 2023Yearly · 2023-12-31 | Product | Product XPHOZAH | 2,464,000 | USD | 0001437402-26-000013 |
| FY 2022Yearly · 2022-12-31 | Geography | Asia Pacific | 31,000 | USD | 0001628280-25-006653 |
| FY 2022Yearly · 2022-12-31 | Geography | North America | 36,527,000 | USD | 0001628280-25-006653 |
| FY 2022Yearly · 2022-12-31 | Geography | United States | 15,600,000 | USD | 0001628280-25-006653 |
| FY 2022Yearly · 2022-12-31 | Product | License | 35,031,000 | USD | 0001628280-25-006653 |
| FY 2022Yearly · 2022-12-31 | Product | Non Cash Royalty Related To Sale Of Future Royalties | 0 | USD | 0001628280-25-006653 |
| FY 2022Yearly · 2022-12-31 | Product | Product IBSRELA | 15,600,000 | USD | 0001628280-25-006653 |
| FY 2022Yearly · 2022-12-31 | Product | Product Supply Revenue | 1,527,000 | USD | 0001628280-25-006653 |
| FY 2022Yearly · 2022-12-31 | Product | Product XPHOZAH | 0 | USD | 0001628280-25-006653 |
| FY 2021Yearly · 2021-12-31 | Geography | Asia Pacific | 10,084,000 | USD | 0001628280-24-006393 |
| FY 2021Yearly · 2021-12-31 | Geography | North America | 13,000 | USD | 0001628280-24-006393 |
| FY 2021Yearly · 2021-12-31 | Geography | United States | 0 | USD | 0001628280-24-006393 |
| FY 2021Yearly · 2021-12-31 | Product | Collaborative Development | 4,177,000 | USD | 0001628280-24-006393 |
| FY 2021Yearly · 2021-12-31 | Product | License | 5,013,000 | USD | 0001628280-24-006393 |
| FY 2021Yearly · 2021-12-31 | Product | Product | 0 | USD | 0001628280-24-006393 |
| FY 2021Yearly · 2021-12-31 | Product | Product IBSRELA | 0 | USD | 0001628280-24-006393 |
| FY 2021Yearly · 2021-12-31 | Product | Product Supply Revenue | 907,000 | USD | 0001628280-24-006393 |
| FY 2021Yearly · 2021-12-31 | Product | Product XPHOZAH | 0 | USD | 0001628280-24-006393 |
| FY 2020Yearly · 2020-12-31 | Geography | Asia Pacific | 6,765,000 | USD | 0001628280-23-006041 |
| FY 2020Yearly · 2020-12-31 | Geography | Canada | 806,000 | USD | 0001628280-23-006041 |
| FY 2020Yearly · 2020-12-31 | Geography | United States | 0 | USD | 0001628280-23-006041 |
| FY 2020Yearly · 2020-12-31 | Product | Collaborative Development | 5,364,000 | USD | 0001628280-23-006041 |
| FY 2020Yearly · 2020-12-31 | Product | License | 706,000 | USD | 0001628280-23-006041 |
| FY 2020Yearly · 2020-12-31 | Product | Product | 0 | USD | 0001628280-23-006041 |
| FY 2020Yearly · 2020-12-31 | Product | Product Supply Revenue | 1,501,000 | USD | 0001628280-23-006041 |
| FY 2019Yearly · 2019-12-31 | Product | Collaborative Development | 459,000 | USD | 0001628280-22-004226 |
| FY 2019Yearly · 2019-12-31 | Product | License | 4,500,000 | USD | 0001628280-22-004226 |
| FY 2019Yearly · 2019-12-31 | Product | Product Supply Revenue | 322,000 | USD | 0001628280-22-004226 |
| FY 2018Yearly · 2018-12-31 | Geography | Asia Pacific | 287,000 | USD | 0001558370-21-002500 |
| FY 2018Yearly · 2018-12-31 | Geography | North America | 2,320,000 | USD | 0001558370-21-002500 |
| FY 2018Yearly · 2018-12-31 | Product | License | 2,320,000 | USD | 0001558370-20-002138 |
| FY 2018Yearly · 2018-12-31 | Product | Other Product Or Services Revenue | 287,000 | USD | 0001558370-20-002138 |
| FY 2017Yearly · 2017-12-31 | Geography | China | 12,000,000 | USD | 0001558370-20-002138 |
| FY 2017Yearly · 2017-12-31 | Geography | Japan | 30,000,000 | USD | 0001558370-20-002138 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.